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Abstract
Background: Glutathione S transferase (GST) polymorphisms have been considered as risk factors for age-related
cataracts, but the results remain controversial. In this study, we have performed a meta-analysis to evaluate the
association between polymorphisms of GSTM1 and GSTT1 and cataract risk.
Methods: Published literature from PubMed and other databases were retrieved. The case–control studies
regarding the association between GSTM1 or GSTT1 polymorphism and cataract risk were included. Pooled odds
ratio (OR) and 95 % confidence interval (CI) were calculated using random- or fixed-effects model.
Results: Fifteen studies on GSTM1 (3,065 patients and 2,105 controls), and nine studies on GSTT1 (2,374 patients
and 1,544 controls) were included. By pooling all the studies, GSTM1 null polymorphism was not associated with
cataract risk, and this negative association maintained in subgroup analyses. However, GSTT1 null polymorphism
was significantly associated with increased risk of posterior subcapsular (OR, 1.42; 95 % CI, 1.04–1.94) but not other
subtypes of cataract. Stratified analyses demonstrated an association of GSTT1 null genotype with increased risk of
cataract in Asian (OR, 1.44; 95 % CI, 1.14–1.83) but not Caucasian populations. In addition, seven pooled studies
showed no association of cataract risk with the combined GSTM1 and GSTT1 null genotypes.
Conclusions: This meta-analysis suggests that GSTT1 null polymorphism is associated with increased risk of
posterior subcapsular cataract. Given the limited sample size, the association between GSTT1 null polymorphism
and cataract risk in Asian awaits further investigation.
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Background
Cataract is the opacification of eye lens with the break-
down of the lens protein microarchitecture, which ad-
versely affects the transmission of light onto the retina
[1]. Recent data suggest that cataract remains the leading
cause of blindness worldwide, and the age-related cata-
ract accounts for approximately 50 % of blindness cases
[2]. Epidemiologic studies have revealed some environ-
mental risk factors for age-related cataract, including
ultraviolet B light exposure, ionizing radiation, smoking,
and use of steroids [3]. Recently, genetic factors have
been found to play important roles in the pathogenesis
of age-related cataract [4]; furthermore, gene polymor-
phisms have been reported to be associated with age-
related cataract risk [5, 6].
It has been reported that oxidative stress contributes
to development of age-related cataract [7]. Biochemical
evidence demonstrates that generation of excessive re-
active oxygen species (ROS) results in abnormal degrad-
ation, cross linking, and aggregation of lens proteins,
and is involved in cataractogenesis [8]. The oxidative
damage during cataractogenesis can be alleviated by cel-
lular defense mechanisms, including catalase, superoxide
dismutase, glutathione peroxidase, and glutathione S
transferases (GSTs) in the eye [9]. Among them, GSTs
are a superfamily of enzymes that play important roles
in the detoxification, elimination of xenobiotics and
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antioxidation, such as carcinogens, toxins, oxidants and
drugs [10]. This enzymatic superfamily is composed of
three different families: mitochondrial, microsomal and
cytosolic. The cytosolic family of GSTs are classified in
seven classes based on chromosomal location and on
sequence similarity: alpha (GSTA), mu (GSTM), pi (GSTP),
theta (GSTT), kappa (GSTK), zeta (GSTZ) and omega
(GSTO) [11].
Previous studies have identified numerous variants in
GST genes, and some of these polymorphisms are func-
tional, e.g., GSTT1 and GSTM1 null polymorphisms
[12]. In fact, the deletion of GSTT1 or GSTM1 results in
dysfunction of their enzyme activity [12], and these poly-
morphisms of GST are associated with increased risks of
various pathologies including cancers [13] and ophthal-
mologic problems such as glaucoma [14]. The rela-
tionships between GST polymorphisms and risks of
age-related cataract have been studied for many years,
and an early meta-analysis suggested that GSTM1 and
GSTT1 null genotypes were associated with increased
risk for senile cataract in Asians but not Caucasians [6].
However, recent studies showed that GSTM1 positive
(GSTM1+/+) genotype was associated with a susceptibil-
ity to age-related cortical cataract in Asians [15], while
GSTM1 or GSTT1 null genotype was associated with
age-related cataract risk in Caucasians [16, 17]. These in-
consistent results may be due to the relatively small size of
study populations from each individual study, or limited
studies included by the previous meta-analysis; therefore,
in this study we have conducted an update meta-analysis
to reevaluate the associations between GSTM1 and
GSTT1 polymorphisms and age-related cataract risk.
Methods
Identification of eligible studies
To identify all articles that evaluated the association of
GST polymorphism with cataract, we carried out a lit-
erature search in the PubMed databases up to December
Fig. 1 Flow diagram of studies identification
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2014 with the following MeSH terms and keywords:
“cataract”, “glutathione S transferase”, and “polymorphism”.
The manual search was conducted to identify additional
studies from other sources (e.g., Embase, Web of Know-
ledge, China National Knowledge Infrastructure), review
articles on this topic or references to original studies. The
inclusion criteria for eligible studies included in this meta-
analysis as follows: (a) a study evaluating the association
between GSTM1 or GSTT1 null polymorphism and cata-
ract, (b) a case–control study, (c) an unrelated study, if
studies had partly overlapped subjects, only the one with a
larger sample size was selected, (d) a study with available
genotype frequency, and (e) a study with sufficient data for
estimating odds ratio (OR) and 95 % confidence interval
(CI). Our meta-analysis was in accordance with PRISMA
guidelines
Because the data included in this study were retrieved
from the literatures, written informed consent for par-
ticipation and ethical approval have been provided by
original studies. Thus, all investigations analyzed in this
meta-analysis have been carried out in compliance with
the Helsinki Declaration.
Data extraction
Two investigators (W.S. and L.S) independently assessed
the articles for inclusion, and reached a consensus on
data extracted. For each study, the following information
was extracted: the first author name and publication year
of the article; ethnicity (country) of study subjects; gene
polymorphisms and genotype frequencies; sample size
(numbers of cases and controls); sources of controls;
subtypes of cataract classified. The missing data and in-
formation of included studies were obtained by contact-
ing the study authors through email.
Statistical analysis
The association between GSTM1, or GSTT1 polymorph-
ism and cataract was estimated by calculating pooled OR
Table 1 Characteristics of literatures included in the meta-analysis
Author/ Year Country Ethnicity Sample size Cases/controlsa Source of controls Cataract subtype
GSTM1
Sekine 1995 [36] Japan Asian 138/62 (101/30) PB Not classified
Alberti 1996 [35] United States Caucasian 202/98 (99/49) HB NC/CC/M
Pi 1996 [34] China Asian 59/112 (41/57) HB Not classified
Hao 1999 [33] China Asian 77/76 (41/35) HB Not classified
Juronen 2000 [25] Estonia Caucasian 503/202 (240/111) HB CC/NC/ PSC/M
Saadat 2004 [24] Iran Caucasian 150/150 (90/58) HB Not classified
Saadat 2006 [23] Iran Caucasian 95/95 (56/36) HB Not classified
Guven 2007 [18] Turkey Caucasian 195/136 (105/58) HB CC/NC/ PSC/MC
Xu 2007 [32] China Asian 120/118 (81/60) HB Not classified
Azeem 2009 [22] Egypt Caucasian 53/73 (23/46) HB Not classified
Zhou 2010 [21] China Asian 279/145 (171/95) PB Not classified
Sireesha 2012 [16] India Caucasian 455/205 (177/94) PB CC/NC/ PSC/MC
Saadat 2012 [17] Iran Caucasian 186/195 (104/89) HB Not classified
Jiang 2012 [15] China Asian 422/312 (176/173) HB CC
Chandra 2014 [31] India Caucasian 124/126 (43/68) HB Not classified
GSTT1
Juronen 2000 [ 25] Estonia Caucasian 503/202 (73/36) HB CC/NC/PSC/MC
Saadat 2004 [24] Iran Caucasian 150/150 (49/46) HB Not classified
Guven 2007 [18] Turkey Caucasian 195/136 (29/22) HB CC/NC/PSC/MC
Azeem 2009 [22] Egypt Caucasian 53/73 (16/21) HB Not classified
Zhou 2010 [21] China Asian 279/145 (146/60) PB CC/NC/PSC
Sireesha 2012 [16] India Caucasian 455/205 (123/40) PB CC/NC/PSC/MC
Saadat 2012 [17] Iran Caucasian 186/195 (49/57) HB Not classified
Jiang 2012 [15] China Asian 422/312 (221/138) HB CC
Chandra 2014 [ 31] India Caucasian 131/126 (18/5) HB Not classified
Abbreviations: PB population-based, HB hospital-based, CC cortical cataract, NC nuclear cataract, PSC posterior sub-capsular cataract, MC mixed cataract
aThe number of null genotype cases or controls was presented in parenthesis
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and 95 % CI. The significance of the pooled OR was deter-
mined by Z test, in which the P < 0.05 was considered sta-
tistically significant. The risk of GSTM1 or GSTT1 null
genotype on cataract was evaluated by comparing to wild
type homozygote as their reference. Stratified analyses
were also performed by ethnicity of study populations, the
source of controls, gender of subjects, and cataract
subtype. Considering the possible additive effect of differ-
ent GST genotypes, we next evaluated the association be-
tween the genotype profile and cataract risk, in which the
individuals with two putative low-risk genotypes, i.e.,, the
presence of functional GSTM1 and GSTT1 alleles, were
used as reference group [18]. For the quantitative synthesis
analysis, the environmental effects were not adjusted
due to the lack of information from the original study.
The I2-based Q statistic test was applied to examine
variations due to heterogeneity rather than chance. A
random-effects (DerSimonian-Laird method) model or
fixed-effects (Mantel-Haenszel method) model was ap-
plied to calculate pooled effect estimates in the pres-
ence (P ≤ 0.10) or absence (P > 0.10) of heterogeneity.
The Egger’s test [19] and the Begg’s [20] test were ap-
plied to detect publication bias for the overall pooled
analysis of GSTM1 or GSTT1 null genotypes. Addition-
ally, the Begg’s funnel plot was obtained, in which an
asymmetry of the funnel plot indicates a potential pub-
lication bias. The one-way sensitivity analysis was per-
formed when one single study was excluded each time,
and the new pooled results reflect the influence of the
study deleted to the overall OR. All analyses were car-
ried out with Stata software (version 11.0; Stata Corp




By searching PubMed, fifteen abstracts were retrieved
through the search “cataract” “glutathione S transferase”
and “polymorphism”, and nine studies meeting the
inclusion criteria were identified as eligible [15–18,
21–25]. Out of the fifteen, one was meta-analysis [6] and
one was laboratory study [26]. One article was excluded
due to investigation on an association of presenile cata-
racts with heterozygosity for galactosaemic states and
with riboflavin deficiency [27]. We excluded two articles
on the relationship between GST polymorphisms and
risk of age-related macular degeneration [28] or primary
open-angle glaucoma [29]. We also excluded one article
that examined the association of GSTO polymorphisms
with cataract risk [30]. In addition, we included six eli-
gible articles with manual searching [31–36]. As a result,
a total of fifteen articles on GSTM1 or GSTT1 polymor-
phisms meeting the inclusion criteria were identified as
eligible studies (Fig. 1).
Fifteen studies on GSTM1 (3,065 cases and 2,105 con-
trols), and nine studies on GSTT1 (2,374 cases and 1,544
controls) were included in this meta-analysis. For the eth-
nicities, six studies of Asians and eight studies of Cauca-
sians were included on the GSTM1 genotype. As to
GSTT1, two studies of Asians and six studies of Caucasians
were included. We also grouped studies with different
Table 2 Association between GSTM1 or GSTT1 polymorphism
and cataract risk
Groups Na Statistical methodb OR (95 % CI) P
GSTM1
All 15 Random (P < 0.001) 1.17 (0.88–1.57) 0.288
Ethnics
Caucasian 9 Random (P < 0.001) 1.07 (0.753–1.53) 0.712
Asian 6 Random (P < 0.001) 1.37 (0.79–2.40) 0.266
Study design
Population-based 3 Random (P = 0.001) 1.17 (0.58–2.33) 0.666
Hospital-based 12 Random (P < 0.001) 1.18 (0.84–1.65) 0.350
Gender
Male 5 Random (P = 0.035) 0.89 (0.58–1.37) 0.598
Female 5 Random (P < 0.001) 1.02 (0.44–2.32) 0.970
Subtype
Cortical 4 Random (P = 0.086) 0.85 (0.59–1.23) 0.386
Nuclear 4 Random (P = 0.084) 0.97 (0.62–1.52) 0.904
Posterior subcapsular 3 Fixed (P = 0.242) 0.98 (0.72–1.32) 0.879
Mixed 4 Random (P = 0.040) 0.94 (0.60–1.48) 0.792
GSTT1
All 9 Random (P = 0.049) 1.20 (0.96–1.51) 0.105
Ethnics
Caucasian 7 Random (P = 0.058) 1.11 (0.83–1.49) 0.474
Asian 2 Fixed (P = 0.653) 1.44 (1.14–1.83) 0.003
Study design
Population-based 2 Fixed (P = 0.952) 1.54 (1.16–2.05) 0.003
Hospital-based 7 Random (P = 0.063) 1.10 (0.84–1.45) 0.498
Gender
Male 5 Fixed (P = 0.984) 1.29 (0.98–1.70) 0.073
Female 5 Fixed (P = 0.359) 1.28 (0.97–1.69) 0.078
Subtype
Cortical 4 Fixed (P = 0.186) 1.09 (0.82–1.45) 0.555
Nuclear 4 Random (P = 0.062) 0.92 (0.52–1.62) 0.774
Posterior subcapsular 4 Fixed (P = 0.219) 1.42 (1.04–1.94) 0.026
Mixed 3 Random (P = 0.097) 1.21 (0.66–2.20) 0.535
aN: The number of included studies
bA random-effects or fixed-effects model was used in presence (P ≤ 0.10) or
absence (P > 0.10) of heterogeneity of included studies and the P value was
presented in parenthesis
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sources of controls (i.e., population-based or hospital-
based), gender (male or female) and subtypes of cataracts
(e.g., cortical, nuclear, posterior sub-capsular or mixed
cataract). In addition to the study by Juronen et al. [25]
that determined the GSTM1 and GSTT1 phenotypes by
enzyme-linked immunosorbent assay (ELISA), the geno-
typing for GSTM1, or GSTT1 was determined by polymer-
ase chain reaction (PCR) assay in all other studies. The
Table 1 presents the detailed characteristics of each study
included in the meta-analysis.
Quantitative synthesis
Table 2 shows the results of the meta-analysis on the as-
sociation of GSTM1 or GSTT1 null polymorphism with
cataract risk. When pooling all the studies, we found
that GSTM1 null polymorphism was not associated with
cataract risk (Fig. 2a), and this negative association
maintained in either Caucasian or Asian populations
(Table 2). When stratified by the source of controls, gen-
der, or cataract subtype, no association was found be-
tween GSTM1 null polymorphism and cataract risk.
For GSTT1, the overall result showed that GSTT1 null
polymorphism was significantly associated with increased
risk of cataract in Asian (OR, 1.44; 95 % CI, 1.14–1.83)
but not Caucasian populations (Table 2). The positive
association of GSTT1 null polymorphism with increased
risk of cataract was found when pooling studies with
population-based (OR, 1.54; 95 % CI, 1.16–2.05) but not
hospital-based controls. However, there was no association
between GSTT1 null polymorphism and cataract risk in
male or female subjects. Interestingly, GSTT1 null poly-
morphism was associated with risk of posterior subcapsu-
lar (OR, 1.42; 95 % CI, 1.04–1.94) but not other subtypes
of cataract.
We next investigated the effects of the profiles of GST
genotypes on the risk of cataract, and examined the as-
sociation between combinations of GSTM1 and GSTT1
null genotypes and cataract risk. Table 3 displays cata-
ract risk associated with combinations of GST null geno-
types, and the trend in risk associated with each putative
high-risk null genotype. The results showed no associ-
ation between the combined GSTM1 and GSTT1 null
genotypes and cataract risk in all population, Caucasian
or Asian population. When stratified by source of con-
trols, pooled two studies with population-based controls
showed that combination of GSTM1 null and GSTT1
positive (GSTT1+/+) genotypes played a protective role
in cataract risk (OR, 0.71; 95 % CI, 0.54–0.92), but com-
bination of GSTM1 positive and GSTT1 null, or GSTM1
and GSTT1 null genotypes was not associated with cata-
ract risk. The other sub-group analyses showed no asso-
ciation between combination of GSTM1 and GSTT1
polymorphisms and cataract risk.
Potential publication bias and sensitivity analysis
We firstly detected the publication bias by the Begg’s
test for the overall pooled analyses of GSTM1 and
GSTT1 null genotype, and found symmetric distribution
of corresponding funnel plots for GSTM1 genotype with
a P value of 0.138, and GSTT1 genotype with a P value
of 0.754 (Fig. 3). However, the Egger’s test showed that
the P values for GSTM1 and GSTT1 null genotype were
0.037 and 0.908 respectively, suggesting a publication
bias for studies on GSTM1 but not GSTT1 genotype.
Sensitivity analysis showed that exclusion of each study
did not influence the result in specific genotype compari-
son for GSTM1 and GSTT1 polymorphism (Fig. 4), sug-
gesting that the results of synthetic analysis were robust.
Fig. 2 Forest plots of the association between GSTM1 or GSTT1 null polymorphism and cataract risk. The random-effects or fixed model was used
to calculate the pooled effect estimates of the effects of GSTM1 (a) or GSTT1 (b) null polymorphism on cataract risk respectively. The squares and
horizontal lines correspond to OR and 95 % CI of specific study, and the area of squares reflects study weight (inverse of the variance). The diamond
represents the pooled OR and its 95 % CI
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Table 3 Association between GSTM1 and GSTT1 polymorphisms and cataract risk
Groups Numbera Statistical methodb OR (95 % CI) P
All
GSTM1 null + GSTT1 positive 7 Random (P < 0.001) 0.83 (0.56– 1.23) 0.356
GSTM1 positive + GSTT1 null 7 Fixed (P = 0.240) 1.20 (0.95– 1.53) 0.134
GSTM1 null + GSTT1 null 7 Random (P = 0.010) 1.16 (0.71– 1.89) 0.545
Ethnics
Caucasian
GSTM1 null + GSTT1 positive 6 Random (P < 0.001) 0.85 (0.52– 1.37) 0.494
GSTM1 positive + GSTT1 null 6 Fixed (P = 0.658) 1.00 (0.74– 1.34) 0.983
GSTM1 null + GSTT1 null 6 Random (P = 0.008) 1.27 (0.67– 2.38) 0.466
Study design
PB
GSTM1 null + GSTT1 positive 2 Fixed (P = 0.591) 0.71 (0.54– 0.92) 0.009
GSTM1 positive + GSTT1 null 2 Fixed (P = 0.334) 1.03 (0.69– 1.53) 0.899
GSTM1 null + GSTT1 null 2 Random (P = 0.036) 0.87 (0.34– 2.18) 0.760
HB
GSTM1 null + GSTT1 positive 5 Random (P < 0.001) 0.88 (0.47– 1.65) 0.697
GSTM1 positive + GSTT1 null 5 Fixed (P = 0.196) 1.32 (0.97– 1.79) 0.073
GSTM1 null + GSTT1 null 5 Random (P = 0.024) 1.38 (0.71– 2.69) 0.336
Gender
Male
GSTM1 null + GSTT1 positive 2 Fixed (P = 0.990) 0.88 (0.49– 1.59) 0.676
GSTM1 positive + GSTT1 null 2 Fixed (P = 0.476) 0.84 (0.28– 2.50) 0.749
GSTM1 null + GSTT1 null 2 Fixed (P = 0.672) 1.48 (0.52– 4.21) 0.463
Female
GSTM1 null + GSTT1 positive 2 Random (P < 0.001) 0.79 (0.06– 10.87) 0.858
GSTM1 positive + GSTT1 null 2 Fixed (P = 0.767) 0.62 (0.27– 1.43) 0.264
GSTM1 null + GSTT1 null 2 Random (P = 0.074) 0.91 (0.15– 5.57) 0.919
Cataract type
Cortical
GSTM1 null + GSTT1 positive 3 Fixed (P = 0.745) 0.82 (0.62– 1.10) 0.181
GSTM1 positive + GSTT1 null 3 Fixed (P = 0.131) 1.39 (0.99– 1.96) 0.061
GSTM1 null + GSTT1 null 3 Fixed (P = 0.171) 1.03 (0.72– 1.48) 0.855
Nuclear
GSTM1 null + GSTT1 positive 2 Random (P = 0.030) 1.00 (0.39– 2.56) 0.994
GSTM1 positive + GSTT1 null 2 Random (P = 0.081) 0.67 (0.11– 4.24) 0.668
GSTM1 null + GSTT1 null 2 Fixed (P = 0.868) 1.16 (0.56– 2.38) 0.694
Posterior subcapsular
GSTM1 null + GSTT1 positive 2 Random (P = 0.038) 1.20 (0.42– 3.39) 0.734
GSTM1 positive + GSTT1 null 2 Fixed (P = 0.157) 1.15 (0.59– 2.26) 0.682
GSTM1 null + GSTT1 null 2 Fixed (P = 0.399) 1.97 (0.98– 3.97) 0.059
Mixed
GSTM1 null + GSTT1 positive 2 Random (P = 0.019) 0.81 (0.25– 2.61) 0.724
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Discussion
Before inclusion of studies, we briefly searched PubMed,
Embase, Web of Science and China National Knowledge
Infrastructure, and found that most of studies examined
association of GSTM1 or GSTT1 polymorphisms with
cataract risk while very limited studies were related to
other GST polymorphisms, e.g., GSTM3, GSTO or GSTP
polymorphisms. Thus, this meta-analysis only evaluated
the effects of GSTM1 and GSTT1 ploymorphisms on
cataract risk. Our data showed that GSTT1 but not
GSTM1 null polymorphism was associated with cataract
risk in Asians. Although different subtypes of cataract
have their own pathogenesis and clinical characteristics,
our meta-analysis data indicate that GSTT1 null poly-
morphism may contribute to increased risk of posterior
subcapsular cataract.
In 1995, Sekine and colleagues for the first time re-
ported possible correlation of GSTM1 null genotype fre-
quency with cataract risk [36]. However, the following
studies showed inconsistent results [18, 21–25, 32–35].
By pooling these early studies, previous meta-analysis by
Sun et al., did not find an association of GSTM1 null
genotype with cataract risk [6]. Even including three
more studies, we did not find positive relationship be-
tween GSTM1 null genotype and cataract risk. To be
noted, although previous meta-analysis indicated an as-
sociation of GSTM1 null genotype and increased risk of
cataract in Asians [6], our data did not confirm this as-
sociation when including one more study on Asians.
For GSTT1 polymorphism, pooled four early studies
on Caucasian showed no association [18, 22, 24, 25]
while one study on Asians [21] showed positive associ-
ation between GSTT1 null genotype and cataract risk;
however, by pooling these five studies, no association
was found [6]. By including four recent studies, our
meta-analysis showed positive association of GSTT1
polymorphism with increased risk of cataract in all pop-
ulations, and this association remained in Asians when
two studies were pooling [15, 21]. Previous studies re-
ported gender-dependent effects of GSTT1 null poly-
morphism on cataract risk [18, 22, 24]; however, recent
two studies showed negative results [15, 16]. We per-
formed a subgroup analysis stratified by gender with all
five studies, and results showed no significant associ-
ation, which was consistent with previous meta-analysis
data based on three studies [6]. In addition, our data
showed positive association of GSTT1 null polymorph-
ism with increased risk of posterior subcapsular cataract
although previous pooled study indicated that this asso-
ciation did not reach significant (OR, 1.21; 95 % CI,
0.96–1.53) [6]. Since the studies included for subgroup
analyses were still limited, future studies are required to
validate the association between GSTT1 null polymorph-
ism and cataract risk.
To the best of our knowledge, the association be-
tween combination of GST polymorphisms and suscep-
tibility to cataract has been assessed for the first time
by our meta-analysis. The study by Juronen et al.,
firstly reported that the GSTM1 positive phenotype fre-
quency was significantly higher in the cataract group
than in the controls, and the cataract risk associated
with the GSTM1 positive phenotype was increased in
Table 3 Association between GSTM1 and GSTT1 polymorphisms and cataract risk (Continued)
GSTM1 positive + GSTT1 null 2 Fixed (P = 0.130) 1.22 (0.68– 2.21) 0.505
GSTM1 null + GSTT1 null 2 Fixed (P = 0.523) 1.44 (0.74– 2.79) 0.279
aN: The number of included studies
bA random-effects or fixed-effects model was used in presence (P ≤ 0.10) or absence (P > 0.10) of heterogeneity of included studies and the P value was presented
in parenthesis
Fig. 3 Funnel plots showed symmetric distribution. Log OR is plotted against the standard error of log OR for studies on GSTM1 (a) or GSTT1 null
(b) polymorphism. The dots represent specific studies for the indicated association
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carriers of the combined GSTM1 positive and GSTT1
positive phenotypes [25]. However, a later study by
Saadat et al., showed that individuals with the null
genotypes for GSTM1 and GSTT1, or combination of
GSTT1 positive and GSTM1 null genotypes were at a
significantly higher risk for developing cataract than in-
dividuals with both the genes positive genotypes [24].
The following studies consecutively presented incon-
sistent results [15, 16, 18, 22]. By pooling seven studies,
our meta-analysis results did not show a significant as-
sociation between each combination of GSTM1 and
GSTT1 genotypes and cataract risk. Two pooled studies
with population-based controls showed that combin-
ation of GSTM1 null and GSTT1 positive genotypes
played a protective role in cataract risk [16, 25]; how-
ever, this positive association was not found in other
stratified analyses. Thus, the result should be inter-
preted with caution.
When compared to individual studies, the meta-
analysis has a vital advantages. However, some potential
limitations in our study should be considered. First, the
inclusion of studies might not be sufficient since we
only included published papers with language in
English, or Chinese. It is possible that some papers
published in other languages may not indexed by the
database (e.g. PubMed, Embase, Web of Science). Thus,
the publication bias for GSTM1 polymorphism detected
in our study might be due to insufficient inclusion of
published studies. Second, this meta-analysis was lim-
ited by the small sample size, especially in subgroup
analyses aforementioned (e.g., studies on GSTT1
polymorphism in Asians), and this need further in-
vestigation. Third, basic methodological differences
among the studies, e.g., ELISA vs. PCR assay for
genotyping, might have affected the results. Fourth,
most of the studies included did not categorize the
cataract patients as cortical, nuclear, posterior sub-
capsular and mixed cataract. Although we found
positive association between GSTT1 null polymorph-
ism and increased risk of posterior subcapsular cata-
ract, however, only four studies with available data
were pooled [16, 18, 21, 25], and thus this associ-
ation awaits further confirmation. Fifth, the primary
outcome measure was calculated based on individual
unadjusted ORs, which might affect the evaluation
precision of the study. The lack of detailed data in
each study prevented multiple testing for combined
effects of gene-environment factors on cataract risk,
and thus future studies should address this point.
Last, the Caucasian and Asian subjects from differ-
ent countries might have been genetically heteroge-
neous, e.g., different lifestyle and environment (e.g.,
European vs. Arabian). These factors may explain the
heterogeneity in this meta-analysis for Caucasian
subjects.
Conclusion
In summary, the present meta-analysis showed that
the association between GSTM1 null polymorphism
and cataract risk was either negative or evidence lim-
ited. The GSTT1 null polymorphism was significantly
associated with increased risk of posterior subcapsular
cataract. Given the limited study populations, more
studies with large study population are suggested to
further validate the relationship between GST poly-
morphisms and genetic predisposition to cataract, e.g.,
association of GSTT1 null polymorphism with cataract
risk in Asian.
Fig. 4 Sensitivity analyses for GSTM1 or GSTT1 null polymorphism. Sensitivity analysis was performed for GSTM1 (a) or GSTT1 null (b)
polymorphism. Each study was deleted at a time in synthetic analysis to detect the influence of the omitted study. The hollow circles
represent OR of pooled results with the deletion of each study. The ranges of horizontal dotted-lines represent the 95 % confidence intervals
of the corresponding OR
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